ACTIVATE in Public Housing

NACompletedINTERVENTIONAL
Enrollment

400

Participants

Timeline

Start Date

July 1, 2024

Primary Completion Date

November 30, 2024

Study Completion Date

December 2, 2024

Conditions
PneumoniaInfluenzaVaricella ZosterMeningitisCOVID-19Vaccine Hesitancy
Interventions
BEHAVIORAL

Increasing Willingness and Uptake of Influenza, Pneumonia, Meningitis, HZV, and COVID-19 Vaccination

Provide/enhance knowledge, modify attitudes, motivate and provide skills and resources to reduce Influenza, Pneumonia, Meningitis, HZV, and COVID-19 vaccine hesitancy and increase willingness and uptake in Influenza, Pneumonia, Meningitis, HZV, and COVID-19 vaccination.

Trial Locations (1)

90059

Charles R. Drew University of Medicine & Science, Los Angeles

All Listed Sponsors
lead

Charles Drew University of Medicine and Science

OTHER

NCT06075732 - ACTIVATE in Public Housing | Biotech Hunter | Biotech Hunter